1. Home
  2. TIPT vs VOR Comparison

TIPT vs VOR Comparison

Compare TIPT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiptree Inc.

TIPT

Tiptree Inc.

HOLD

Current Price

$17.21

Market Cap

634.8M

Sector

Finance

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$14.97

Market Cap

755.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIPT
VOR
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
634.8M
755.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
TIPT
VOR
Price
$17.21
$14.97
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$45.33
AVG Volume (30 Days)
208.3K
1.3M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
1.39%
N/A
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$488,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.49
$0.13
52 Week High
$27.38
$49.95

Technical Indicators

Market Signals
Indicator
TIPT
VOR
Relative Strength Index (RSI) 57.28 48.75
Support Level $17.15 $11.38
Resistance Level $18.15 $16.88
Average True Range (ATR) 0.32 1.57
MACD 0.09 -0.08
Stochastic Oscillator 81.12 21.95

Price Performance

Historical Comparison
TIPT
VOR

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: